Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02091960 |
|---|---|
| Brief Title: | A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer |
| First Submitted : | March 18, 2014 |
| First Submitted that Met QC Criteria : | March 18, 2014 |
| First Posted : | March 19, 2014 (Estimate) |
| Results First Submitted : | February 27, 2018 |
| Results First Submitted that Met QC Criteria : | April 18, 2018 |
| Results First Posted : | May 16, 2018 |
| Last Update Submitted that Met QC Criteria : | September 18, 2018 |
| Last Update Posted : | October 17, 2018 |